Our Story
Over the Years
NOVEMBER 2024
Berkeley SkyDeck Europe
- GeneSys Bio selected to participate in the Berkeley SkyDeck accelerator program
SEPTEMBER 2024
The Rome Startup Week 2024
- during theGeneSys Bio selected from more than 120 applicants to participate in the Startup Program durante la Rome Startup Week 2024
SEPTEMBER 2024
Plug and Play – Showcase
- GeneSys Bio selected to present in front of more than 100 VC investors with a combined AUM of more than $10 billion
JULY 2024
EIT Health Open Innovation Programme
- GeneSys Bio is selected among the most innovative approaches in Europe for diagnosing Sexually Transmitted Diseases and participates in EIT Health Open Innovation Programme’s STI Challenge.
JUNE 2024
Pre-Seed Plus by Lazio Innova
- GeneSys Bio wins the maximum grant made available by Lazio Innova through the Pre-Seed Plus call for proposals
JUNE 2024
WMF | We Make Future
- GeneSys Bio is selected to present its project during the World Startup Fest, part of the We Make Future 24
MAY 2024
Boost Your Ideas by Lazio Innova
- GeneSys Bio, selected from more than 200 startups, wins first prize in Boost Your Ideas program organized by Lazio Region and Lazio Innova
APRIL 2024
Maverx Innovation Bootcamp
- GeneSys Bio partecipa al MaverX Innovation Bootcamp e Pitch presentation ed entra in contatto con interessanti attori della Biomedical Valley
MARCH 2024
First patent filing
- GeneSys Bio files patent application for kit dedicated to Urinary Tract Infections
MARCH 2024
BBS Startup Ecosystem Day + Hackaton
- GeneSys Bio is selected by the prestigious Bologna Business School to participate in the Startup Ecosystem Day And be the subject of a business hackathon
OCTOBER 2023
Fundable
- GeneSys Bio wins first Fundable event dedicated to startups in product development stage
OCTOBER 2023
Meet In Italy For Life Sciences 2023
- GeneSys Bio is selected to present its project at MIT4LS, one of Italy’s premier events for life sciences startups
SEPTEMBER 2023
EIT Health Bridgehead Europe – Siemens Healthineers
- The GeneSys project is selected within EIT Health’s Bridghead Europe program and is selected by Siemens Healthineers for the matchmaking phase
SEPTEMBER 2023
POC development
- The Proof-Of-Concept of the device is realized.
JULY 2023
Next Age
- The GeneSys project completes the Next Age acceleration path created on the initiative of CDP Venture Capital and AC75 Startup Accelerator, obtaining the first investment
MAY 2023
GeneSys Bio Ltd. is born
- Andrea, Enrico, Simone and Luciano found GeneSys Bio with the goal of bringing their innovation to market
